Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease.
Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Boxer AL, et al. Among authors: baker sl. Neurology. 2007 Jul 17;69(3):283-90. doi: 10.1212/01.wnl.0000265815.38958.b6. Neurology. 2007. PMID: 17636066
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust WJ. Rabinovici GD, et al. Among authors: baker sl. Neurology. 2007 Apr 10;68(15):1205-12. doi: 10.1212/01.wnl.0000259035.98480.ed. Neurology. 2007. PMID: 17420404
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.
Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD. Rosenbloom MH, et al. Among authors: baker sl. Neurology. 2011 May 24;76(21):1789-96. doi: 10.1212/WNL.0b013e31821cccad. Epub 2011 Apr 27. Neurology. 2011. PMID: 21525424 Free PMC article.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.
Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative. Landau SM, et al. Among authors: baker sl. Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407. doi: 10.1007/s00259-014-2753-3. Epub 2014 Mar 20. Eur J Nucl Med Mol Imaging. 2014. PMID: 24647577 Free PMC article.
Individuals with Alzheimer's disease and low tau burden: Characteristics and implications.
Landau SM, Lee J, Murphy A, Ward TJ, Harrison TM, Baker SL, DeCarli C, Harvey D, Tosun D, Weiner MW, Koeppe RA, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Landau SM, et al. Among authors: baker sl. Alzheimers Dement. 2024 Mar;20(3):2113-2127. doi: 10.1002/alz.13609. Epub 2024 Jan 19. Alzheimers Dement. 2024. PMID: 38241084 Free PMC article.
[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.
Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S, VandeVrede L, Heuer HW, Ljubenkov P, Rojas JC, Chen MK, Amuiri AN, Miller Z, Gorno-Tempini ML, Miller BL, Rosen HJ, Litvan I, Grossman M, Boeve B, Pantelyat A, Tartaglia MC, Irwin DJ, Dickerson BC, Baker SL, Boxer AL, Rabinovici GD, La Joie R. Blazhenets G, et al. Among authors: baker sl. J Nucl Med. 2023 Dec 1;64(12):1980-1989. doi: 10.2967/jnumed.123.265856. J Nucl Med. 2023. PMID: 37918868
204 results